ARTICLE | Emerging Company Profile
Cellino: Automating complex production, differentiation of iPS cells into cell therapies
Via $80M A round for manufacturing play, Bayer deepens its reach into next-gen cell therapy technologies
January 26, 2022 2:18 AM UTC